AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03081013 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social information
Description: Social comparison information will be provided to the study participants weekly via SMS
Study NCT03081013 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Fitbit
Description: Fitbit is a wireless pedometer that tracks steps of participants and will be offered in conjunction with a tailored website with customised information for participants.
Study NCT03081013 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Fitbit
Description: Fitbit is a wireless pedometer that tracks steps of participants and will be offered in conjunction with a tailored website with customised information for participants.
Study NCT05145205 — intervention group
Intervention type: PROCEDURE
Intervention: Sleeve gastrectomy
Description: Bougie was applied over the lower curvature to adjust the gastric tube then longitudinal amputation of the stomach was performed for about 4 to 6 cm per pecker of the pylorus to the corner of His. No supportive materials were used, and over-suturing of the basic line performed only over the points of bleeding.~All resected specimens were sent to histopathology laboratory for examination.
Study NCT05145205 — intervention group
Intervention type: PROCEDURE
Intervention: Laparoscopic Roux-en-Y gastric bypass
Description: An antecolic and antegastric RYGB become executed with a 150 cm alimentary limb with both a linearly or circularly kink (25 mm) gastrojejunostomy in step with the desire of the surgeon. A 50-cm-lengthy biliopancreati
Study NCT04132167 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: perturbation training
Description: exercises for body stability in different positions (bridge, sitting, quadrupedal, half- kneeling, kneeling, standing, monopodalic) performed with visual biofeedback; transfers training performed in front of a mirror; ambulation training with courses drawn on the ground in a straight line and with more complex tracks with visual controlin particular using the protocols seated balance/strength training, standing bal- ance/weight-bearing training, mobility training and closed-chain training;
Study NCT04132167 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: perturbation training
Description: exercises for body stability in different positions (bridge, sitting, quadrupedal, half- kneeling, kneeling, standing, monopodalic) performed with visual biofeedback; transfers training performed in front of a mirror; ambulation training with courses drawn on the ground in a straight line and with more complex tracks with visual controlin particular using the protocols seated balance/strength training, standing bal- ance/weight-bearing training, mobility training and closed-chain training;
Study NCT01255514 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: high dose dexamethsone
Description: high dose dexamethasone : 40mg/day , D1-D4, D9-D12, IV or PO, repeat every 21days for 2cycles
Study NCT02269813 — intervention group
Intervention type: OTHER
Intervention: BluePrint
Study NCT02269813 — intervention group
Intervention type: OTHER
Intervention: TargetPrint
Study NCT01099566 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prasugrel
Description: Prasugrel will be given as loading dose (60mg) on the first trial day two hours prior to endotoxin infusion. Prasugrel is an orally administered prodrug that is converted in the liver by CYP to its active metabolite.
Study NCT01099566 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: A pharmacist not otherwise involved in the trial will encapsulate pills consisting of lactose-starch. Six pills will be administered as placebo 2 hours before LPS administration on trial day 1.
Study NCT04551651 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ApplTree
Description: App downloaded on the participants phone, a short video tutorial session to explain use, and technical support throughout trial period.
Study NCT04551651 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Google Calendar
Description: App downloaded on the participants phone, a short video tutorial session to explain use, and technical support throughout trial period.
Study NCT02330588 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Eat It
Description: The SBIRT (Screening, Brief Intervention, Referral to Treatment), called RIPPLE (Resource Information Program for Parents on Lifestyle Education) was delivered on a study-designated tablet and designed to (1) screen children's weight status, (2) deliver a brief intervention\*, and (3) provide parents with the opportunity select resources and services to help prevent obesity in children.~\*Two brief questions about children's grain portion sizes and sugar sweetened beverage intake were presented.
Study NCT02330588 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Move It
Description: The SBIRT (Screening, Brief Intervention, Referral to Treatment), called RIPPLE (Resource Information Program for Parents on Lifestyle Education) was delivered on a study-designated tablet and designed to (1) screen children's weight status, (2) deliver a brief intervention\*, and (3) provide parents with the opportunity select resources and services to help prevent obesity in children.~\*Two brief questions about children's moderate-to-vigorous physical activity (MVPA) and screen time were presented.
Study NCT02330588 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: eHealth Control
Description: The eHealth Control group (1) screened children's weight status, and (2) provided parents with the opportunity select resources and services to help prevent obesity in children.
Study NCT03824873 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Internal iliac artery ligation
Description: Internal iliac artery ligation and cesarean hysterectomy
Study NCT03824873 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: cesarean hysterectomy
Description: cesarean hysterectomy
Study NCT01946568 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dalbavancin
Description: Intravenous dalbavancin given at 15 mg/kg (not to exceed 1000 mg) for patients ≥5 years of age, and 25 mg/kg for patients \<5 years of age.
Study NCT01594411 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Corus CAD
Description: Age/Sex/Gene Expression Score (ASGES)
Study NCT04132128 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: carbohydrate counting
Description: taught how to count carbohydrates in their diet with their personal tool
Study NCT04132128 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: carbohydrate counting
Description: taught how to count carbohydrates in their diet with their personal tool
Study NCT02251028 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Value-based cognitive-behavioral therapy
Description: The intervention is a manualized program specifically tailored for prevention of disability and psychological distress after whiplash injuries. The intervention is delivered by two trained clinical psychologists og consists of 10 weekly one-hour individual sessions.
Study NCT03797144 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CD HORIZON® Fenestrated Screw System with Fenestrated Screw Cement
Description: The CD HORIZON® Legacy™ and Solera™ Fenestrated Screw Spinal System consists of a variety of cannulated screws with a series of fenestrations to allow polymethylmethacrylate (PMMA) bone cement (Fenestrated Screw Cement) to be injected into the treated site. The Fenestrated Screw Cement is used to augment screw fixation in subjects with compromised bone quality.
Study NCT03085212 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stress Free Now
Description: Online stress management program developed by the Cleveland Clinic that uses mindfulness and cognitive-behavioral therapy to help individuals manage their stress.
Study NCT03085212 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Stress Free Now
Description: Online stress management program developed by the Cleveland Clinic that uses mindfulness and cognitive-behavioral therapy to help individuals manage their stress.
Study NCT02809391 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Orthotics alone
Description: The sole thin sport orthotic will be heat moulded to participants footwear. A top cover will be used of similar cushioning thickness and durometer properties as the orthotics+texture intervention.
Study NCT02809391 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Orthotics+textured top cover
Description: The sole thin sport orthotic will be heat moulded to participants footwear. A textured material will be used as the orthotic top cover in this intervention.
Study NCT02573506 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: split-course radiotherapy
Description: Patients are irradiation at a palliative dose in the initial course: 51Gy/17f to PTV-GTV. The disease is re-evaluated three weeks after the end of the initial course using CT. The patient without disease progression according to the RECIST criteria and had a recovery of lung function should get the additional boost. In the second course, the tumor is repositioned and scanned. The residual tumor is then treated with the second course of radiotherapy. A dose of 15-18 Gy/5-6f is delivered to the residue tumor.
Study NCT02573506 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Concurrent chemotherapy
Description: Concurrent chemotherapy consists of weekly docetaxel(25mg/㎡) and nedaplatin(25mg/㎡), each of 1 day's duration.
Study NCT02610894 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mHealth application (PoCAH)
Description: Participants will have unlimited access to the mHealth app via iPad Mini for 5 days post-operatively to aid in pain management
Study NCT02610894 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: As usual standard discharge and care instructions
Description: As usual standard discharge and care instructions are provided via iPad mini to orthopaedic ambulatory surgery patients.
Study NCT02144376 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Ispaghula
Study NCT02144376 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Maltodextrin
Study NCT01697189 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Fatigue management training
Description: Experimental group took part in a single half-day (4 hours) fatigue management training grounded on Problem Based Learning (PBL).
Study NCT00348075 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Neurovision
Study NCT03439722 — intervention group
Intervention type: OTHER
Intervention: Polysomnography
Description: Participants will be admitted for 1 night at the Danish Center of Sleep Medicine for polysomnography.
Study NCT01833910 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: AHA CPR Anytime Video Self-Instruction Kit
Description: CPR Training utilizing a video self-instruction kit including training video and inflatable manikin.
Study NCT01833910 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: AHA CPR Anytime DVD
Description: A CPR Training Video, originally developed as part of a kit, administered without the accompanying manikin.
Study NCT04211792 — intervention group
Intervention type: DEVICE
Intervention: Icare Tonometer
Description: Icare tonometers are a new class of rebound tonometers for IOP measurements. The Icare series of tonometers are hand-held tonometers, which are easy to operate and generally do not require topical anaesthesia for IOP measurements.
Study NCT00684710 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PAZ-417
Study NCT00684710 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT02700620 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Internet-delivered CBT
Description: Guided internet treatment
Study NCT00811291 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Vitamine-B and Folic Acid Complex, calcium
Description: 90 days of intake, will be given in drink (e.g. tea, milk, juice). Dosage within official recommendations for kindergarten kids
Study NCT00811291 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: calcium
Description: according to protocol
Study NCT04147208 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GLS4
Description: Administered GLS4 120 mg orally three times daily in fed state
Study NCT01369667 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin D3
Study NCT01369667 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT02717429 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness Meditation
Description: The mindfulness meditation-training program is closely modeled after the 8-week mindfulness based stress reduction protocol developed by Dr. Jon Kabat-Zinn. The briefer four weeks of MMT involve the practice of concentrative attention, where different objects are used as the focus of meditative practices. For example, for the first two weeks, the investigators use breath as an anchor for attention. With repeated practices, the objects of sensations, emotions, and thought processes are introduced.
Study NCT02717429 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Computerized Cognitive Training
Description: The control group, which will be used to compare the effects of mindfulness training on emotional and cognitive functioning of MS patients, will comprise of a cognitive training group, which will provide an attentional-training based approach. In this group, the focus will be to provide the individuals with cognitive training tasks to complete that have been shown to improve attentional ability. The investigators will also discuss relevant MS-related material on cognitive deficits during these courses.
Study NCT04788485 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Diosmectite
Description: use of diosmectite as a food thickener in neonates in with gastroesophageal reflux in noenates
Study NCT04147208 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RTV
Description: Administered RTV 100 mg orally three times daily in fed state
Study NCT04147208 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ETV
Description: Administered orally ETV 0.5 mg once daily in fasted state
Study NCT04147208 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ETV
Description: Administered orally ETV 0.5 mg once daily in fasted state
Study NCT01238874 — intervention group
Intervention type: DEVICE
Group type: NO_INTERVENTION
Intervention: Cardiac Resynchronization Therapy
Description: All market-approved Medtronic CRT-D and CRT-P devices will be used in this study. All eligible devices are commercially released and will be used within their intended use per device labeling. The study may include future market-approved devices as they become commercially available. All market-approved leads may be used in the study. Epicardial leads may be used in the study.
Study NCT02136329 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sildenafil
Description: The active study drug, Revatio®, is the citrate salt of sildenafil, a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type-5 (PDE5). Sildenafil citrate is designated chemically as 1-\[\[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo \[4,3-d\] pyrimidin-5-yl)-4-ethoxyphenyl\] sulfonyl\]-4-methylpiperazine citrate.~The active study medication is supplied in single use glass vials and as a clear, colourless, sterile, ready-to-use solution containing 10 mg (12.5 mL) of sildenafil. Each mL of solution contains 1.124 mg sildenafil citrate, 50.5 mg dextrose and water for injection.~Sildenafil is manufactured under Good Manufacturing Practice (EU-GMP) by Pfizer Inc
Study NCT04221659 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transcranial Direct Current Stimulation
Description: Participants will receive 16 sessions of Transcranial Direct Current Stimulation (tDCS) for 20 minutes each at 2 mA intensity, on alternate days (3 times a week). The current will be delivered via saline-embedded sponge surface electrodes using a battery-powered neurostimulator (TCT-Research, Trans Cranial Technologies, Hong Kong). A small active specific electrode (5x5 cm) will be used to prevent coverage of adjacent areas, resulting in a current density of 0.08 mA / cm². The cathode, reference electrode (5x7cm), will be positioned in the occipital region. These parameters are within the safe limits established in previous human studies.
Study NCT04221659 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Direct Current Stimulation
Description: Participants will receive 16 sessions of Transcranial Direct Current Stimulation (tDCS) for 20 minutes each at 2 mA intensity, on alternate days (3 times a week). The current will be delivered via saline-embedded sponge surface electrodes using a battery-powered neurostimulator (TCT-Research, Trans Cranial Technologies, Hong Kong). A small active specific electrode (5x5 cm) will be used to prevent coverage of adjacent areas, resulting in a current density of 0.08 mA / cm². The cathode, reference electrode (5x7cm), will be positioned in the occipital region. These parameters are within the safe limits established in previous human studies.
Study NCT01784328 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Peristeen Bowel Irrigation System
Description: A complete system for bowel Irrigation to manage bowel dysfunction
Study NCT03194659 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Choline
Description: Choline chloride is a water soluble choline salt that will be provided in a juice solution to participants to be consumed daily. The intervention will increase dietary choline intake by 500mg/day.
Study NCT02189772 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metadoxine extended release
Description: MG01CI
Study NCT02189772 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Inactive drug
Study NCT00550615 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dasatinib
Description: Dasatinib will be orally administered once daily for 28 day cycles.~There will be three dose cohorts for the Dasatinib in the Phase I portion of this trial. A minimum of three patients will be enrolled into each of the following dose cohorts:~Dose cohort # 1 will be 100 mg per day Dose cohort # 2 will be 150 mg per day Dose cohort # 3 will be 200 mg per day~The MTD will be determined in the Phase I portion of this trial.
Study NCT00550615 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dasatinib Maximum Tolerated Dose
Description: An additional 29 patients using the Two-Stage Simon design will be enrolled into Phase II using the MTD determined in Phase I.
Study NCT04111926 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: A loading dose of dexmedetomidine (0.6 μg/kg) was administered during a 10-minute period before anaesthesia induction, followed by a continuous infusion at a rate of 0.5 μg/kg/hr till 1 hour before the end of surgery.
Study NCT04111926 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Volume-matched normal saline was administered in the same rate for the same duration as in the intervention group.
Study NCT00641745 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lurasidone HCl
Description: 40 - 120mg per day
Study NCT00641745 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Risperidone
Description: Risperidone
Study NCT01950364 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: brentuximab vedotin
Description: Brentuximab vedotin will be administered every 3 weeks at a dose of 1.8 mg/kg.
Study NCT01950364 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Brentuximab vedotin and rifampicin
Description: Brentuximab vedotin will be administered every 3 weeks at a dose of 1.8 mg/kg beginning on Cycle 1, Day 1; daily rifampicin (600 mg PO) will be administered during Cycles 0 through 3 only, beginning on Cycle 0, Day 1 (7 days before the Cycle 1, Day 1 dose of brentuximab vedotin) and continuing through Cycle 3, Day 21.
Study NCT03583502 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: krill oil and fish oil supplement
Description: Administration of 2 gelatin soft capsules per day of a combined krill and fish oil supplement, providing 250 mg/day of DHA and 70 mg/day of EPA, for overall 30 days.
Study NCT02411006 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Prediction mailing
Description: Ask people to predict their upcoming medication adherence
Study NCT01059344 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Mesalamin
Description: 4.8g/day, 800 mg tablets
Study NCT03339167 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Metabolic availability of lysine in millet
Description: Four levels of lysine intakes will be provided by the reference protein drinks, 3 levels of lysine from millet and 1 level from millet with lentils.
Study NCT03730818 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Water-based Exercise Group
Description: The intervention consist will of a water-based exercise protocol
Study NCT03672812 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Liraglutide
Description: liraglutide 3mg 6/6 hours
Study NCT05076773 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound guided block
Description: Giving one regional block
Study NCT05076773 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: IV morphine
Description: given when VAS>3
Study NCT05076773 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: IV morphine
Description: given when VAS>3
Study NCT00648388 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cilostazol Tablets 100 mg
Description: 100mg, single dose fasting